Corinne Epperly

CIK: 0001839156

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INAB

IN8BIO, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

INAB
IN8BIO, INC.
May 9, 2026
Award(A)
Stock Option (right to buy)
Direct
22K shares-
INAB
IN8BIO, INC.
May 8, 2025
Award(A)
Stock Option (right to buy)
Direct
63.2K shares-
INAB
IN8BIO, INC.
Apr 27, 2025
Disposition(D)
Series B Warrants (right to buy)
Direct
82K shares-
INAB
IN8BIO, INC.
Apr 27, 2025
Award(A)
Series B Warrants (right to buy)
Direct
82K shares-
INAB
IN8BIO, INC.
Dec 19, 2024
Award(A)
Stock Option (right to buy)
Direct
37.7K shares-

		Type	Shares	Price		Ownership
May 9, 2026	INAB IN8BIO, INC.	Award(A) Stock Option (right to buy)	22,000	-	-	Direct
May 8, 2025	INAB IN8BIO, INC.	Award(A) Stock Option (right to buy)	63,150	-	-	Direct
Apr 27, 2025	INAB IN8BIO, INC.	Disposition(D) Series B Warrants (right to buy)	81,967	-	-	Direct
Apr 27, 2025	INAB IN8BIO, INC.	Award(A) Series B Warrants (right to buy)	81,967	-	-	Direct
Dec 19, 2024	INAB IN8BIO, INC.	Award(A) Stock Option (right to buy)	37,655	-	-	Direct

1-5 of 5 transactions

About Epperly Corinne

Epperly Corinne (SEC CIK 0001839156) files insider reports with the SEC as Director of IN8BIO, INC. (INAB).

Signal8 holds 4 ownership filings by Epperly Corinne, all Form 4s, filed between Dec 23, 2024 and May 12, 2026. Those filings report 5 transactions, from Dec 19, 2024 to May 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Epperly Corinne's filings is in NEW YORK, NY.

Recent filings by Epperly Corinne

May 9, 2026: Grant or award of INAB derivative securities (Form 4, code A).
May 8, 2025: Grant or award of INAB derivative securities (Form 4, code A).
Apr 27, 2025: Disposition to issuer transaction of INAB derivative securities (Form 4, code D).
Apr 27, 2025: Grant or award of INAB derivative securities (Form 4, code A).
Dec 19, 2024: Grant or award of INAB derivative securities (Form 4, code A).

Other insiders filing for IN8BIO, INC. (INAB)

FAIRBAIRN EMILY, Director
Ho William Tai-Wei, CEO
Greenwood Luba, Director
Lamb Lawrence, EVP and CSO
McCall Patrick, CHIEF FINANCIAL OFFICER
Rochlin Kate, President and COO

How to read Form 4 transaction codes